Conference Programme

Registration

Opening Remarks

Ro Gardner, Vice-Chair, One Nucleus

Opening Keynote

Off-target Effects of Clinically Approved RAF Inhibitors; a Journey to the Ribosome – Simon Cook, The Babraham Institute

Harnessing the Body’s Defences

Sponsored by

Session MC: Simon Bradbury, Withers & Rogers
Researchers are discovering that many answers to disease prevention and treatment lie within the immune system itself, rather than solely relying on synthetic drugs. This session will showcase innovative approaches that harness the immune system to develop novel immunotherapies that provide more effective treatments for patients.

• 2 Company Case Studies
  • Jake Galson, Alchemab – Pioneering Patient-Led Antibody Discovery
  • James Price, East Anglian Air Ambulance – From Signal to Shield: Biomarkers and Plasma Therapy in Hyperacute Traumatic Brain Injury
• Panel discussion
  • Moderator: Louise Jopling, Babraham Research Campus
  • Panellists: Jake Galson, Alchemab, James Price, East Anglian Air Ambulance, Melanie Leveridge, AstraZeneca & One Nucleus Board Member, Simon Bradbury, Withers & Rogers

Morning Coffee and Networking Break

Adoption of AI in Innovative Drug Discovery

Sponsored by

As AI advances in drug discovery, how does our sector strike the right balance between innovation and ensuring it is used responsibly, that will determine what we can adopt to maximise its impact.

• Keynote presentation
  • Next Generation Drug Discovery – The Convergence of Biology and Technology – Kinga Bercsenyi, Arctoris
• 2 Company Case Studies
  • Catherine Stace, Kuano Limited: Beyond data-driven AI: Incorporating physics-based approaches to enable highly-accurate simulations in drug design
  • Miles Congreve, Isomorphic Labs: Reimagining Drug Discovery using an AI-First Platform
• Panel discussion
  • Moderator: Kinga Bercsenyi, Arctoris
  • Panellists: Peter Brady, Orbital Global Group, Rose Hughes, Evolve IP, Anusha Foy, EY, Catherine Stace, Kuano Limited, Miles Congreve, Isomorphic Labs

Lunch and Networking

Getting Ready for Clinic

Sponsored by

Session MC: Sam Walker, Accelerator Park
This session will highlight the challenges faced in the pre-clinical research space, and how strategic approaches and early decision making can lead to enhanced clinical readiness, reducing costly setbacks and ultimately accelerating the transition from lab to clinic.

• Keynote presentation
  • Johannes Stanta, Bionavix – Strategic Preclinical Pathways to Accelerate Clinical Readiness
• 2 Company Case Studies
  • Dave Cook, Quodria – The 99% Perspiration: Practical Biotech Learnings From Clinical Development
  • Shefali Bohra, DotPlot – Creative Misfits in the Medtech World
• Panel discussion
  • Moderator: Judit Molnar, NeoPhore & One Nucleus Board Member
  • Panellists: Marin Mladinic, PPD, Dave Cook, Quodria, Christopher Floyd, tranScrip, Debra Babalola, DotPlot, Johannes Stanta, Bionavix

Afternoon Coffee and Networking Break

Invention, Innovation, Industrialisation: How to Accelerate the Journey?

Session Sponsored by:

Session MC: Tony Jones, One Nucleus

This session will consider the challenges of translating disruptive innovation to industrial scale adoption. What lessons can be learned from past successes and current trends? There will also be an opportunity to hear insights from an international ecosystem in the way of key learnings from the Boston Bootcamp 2025.

• Panel discussion: Scaling Innovation for Industrial Adoption
  • Moderator: Tony Jones, One Nucleus
  • Panellists: Cathy Tralau-Stewart, The Milner Therapeutics Institute and Consortium, Veronica Gray, LifeArc, Jane Dancer, Non-Executive Director, Claire Thompson, Agility Life Sciences
• Keynote presentation
  • Preeti Bakrania, LifeArc – From Innovation to the Clinic: Establishing Strategic Partnerships Using LifeArc’s Biologic’s Platform Capabilities
• Panel discussion: Key Learnings from the Boston Bootcamp 2025
  • Moderator: Natalie Wood, CK Group
  • Panellists: Hannah Sore, PharmEnable Therapeutics, Jon Telfer, RNAvate, Jason Yip, Tailor Bio, Jamie Renison, Cushman & Wakefield

Closing Remarks

Tony Jones, One Nucleus

Networking Drinks Reception

Sponsored by

End